(Q43508237)

24 November 2017

Mechanism of action of a novel latent membrane protein-1 dominant negative (English)

1 reference

24 November 2017

1 reference

5

1 reference

24 November 2017

Brennan P

1

1 reference

24 November 2017

Floettmann JE

series ordinal

2

1 reference

24 November 2017

Mehl A

series ordinal

3

1 reference

24 November 2017

Jones M

series ordinal

4

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Journal of Biological Chemistry

24 November 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 November 2017

276

1 reference

24 November 2017

2

1 reference

24 November 2017

1195-1203

1 reference

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

24 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Epstein-Barr virus: LMP1 masquerades as an active receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

STAT3 is a serine kinase target in T lymphocytes. Interleukin 2 and T cell antigen receptor signals converge upon serine 727.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Transcription factor activity of STAT proteins: structural requirements and regulation by phosphorylation and interacting proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005461200

21 January 2018

Identifiers

DOI

10.1074/JBC.M005461200

1 reference

24 November 2017

1 reference